A Phase IV, Open Label Study to Evaluate the Short and Long Term Immune Response and CROSS-protection After Vaccination With viroSOME Adjuvanted Inflexal V in Elderly Subjects
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Influenza virus vaccine liposomal (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms CROSSOME
- Sponsors Crucell
- 24 Oct 2012 Status changed from active, no longer recruiting to completed, according to European Clinical trials Database
- 24 Oct 2012 New source identified and integrated European Clinical Trials Database.
- 18 Jul 2012 Planned End Date changed from 1 Jun 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.